ExeGi Pharma gets clearance of IND application for EXE-346 a Live biotherapeutic biologic drug
This clearance allows the company to initiate a clinical trial for patients with an ileal pouch-anal anastomosis
This clearance allows the company to initiate a clinical trial for patients with an ileal pouch-anal anastomosis
The vaccine is under FDA review
105 million 30 µg, 10 µg and 3 µg doses to be delivered into Q4 2022, with an option for the U.S. Government to purchase up to 195 million additional doses
Increased and timely testing will enable early identification of COVID cases and help to curb spread of the infection among the community
The research was supported by the BGU Coronavirus Challenge and the Israeli Ministry of Health.
Real-world evidence from more than 850,000 hospitalized patients provides clinical insights on the use of Veklury (remdesivir) as stand of care Covid-19 treatment
John Shaw, who is a Glasgow University graduate, along with his wife Kiran Mazumdar-Shaw had gifted US $ 7.5 million to the university in July 2019
The method shows the removal of seven types of PFAS – even when all of them are found in the same unit of fluid – at a level of efficiency that approaches 90%, and it does so within a few minutes
The batch will be distributed in India through a partner of RDIF and Panacea Biotec - Dr. Reddy's Laboratories
First batch produced at Panacea Biotec’s facilities at Baddi will be shipped to the Gamaleya Center for quality control and full scale production of the vaccine is due to start this summer
Subscribe To Our Newsletter & Stay Updated